First-line second generation tyrosine kinase inhibitors in patients with newly diagnosed accelerated phase chronic myeloid leukemia.
暂无分享,去创建一个
P. Cony-Makhoul | I. Tigaud | A. Delmer | M. Berger | F. Nicolini | L. Roy | F. Huguet | G. Étienne | A. Charbonnier | D. Réa | A. Andreoli | S. Morisset | C. Orvain | J. Ianotto | M. Balsat | F. Larosa | L. Legros | M. Meunier | E. Cayssials | S. Amé | H. Johnson-Ansah | M. Escoffre‐Barbe | V. Alcazer | M. Escoffre-barbe